-
Why The New MannKind Management Could Focus On R&D, Not A Potential Sanofi Merger
Monday, January 12, 2015 - 4:44pm | 180Read More...Speaking to Benzinga, Griffin Securities Analyst Dr. Keith Markey said that after MannKind Corporation (NASDAQ: MNKD) founder Alfred Mann retires from his role as CEO, the new management will probably not pursue a merger with Sanofi SA (ADR) (NYSE: SNY). "I think what they’re going...
